Ballentine Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$953K Sell
19,724
-6,339
-24% -$306K 0.01% 332
2025
Q1
$1.45M Buy
26,063
+10,617
+69% +$589K 0.03% 232
2024
Q4
$745K Buy
15,446
+2,802
+22% +$135K 0.01% 342
2024
Q3
$729K Buy
12,644
+2,296
+22% +$132K 0.01% 346
2024
Q2
$502K Buy
10,348
+2,371
+30% +$115K 0.01% 407
2024
Q1
$388K Buy
7,977
+539
+7% +$26.2K 0.01% 458
2023
Q4
$370K Buy
7,438
+402
+6% +$20K 0.01% 442
2023
Q3
$377K Buy
7,036
+600
+9% +$32.2K 0.01% 379
2023
Q2
$347K Buy
6,436
+2,696
+72% +$145K 0.01% 412
2023
Q1
$204K Buy
+3,740
New +$204K 0.01% 521
2022
Q3
Sell
-5,322
Closed -$267K 491
2022
Q2
$267K Sell
5,322
-3,306
-38% -$166K 0.01% 345
2022
Q1
$443K Buy
+8,628
New +$443K 0.01% 276
2021
Q4
Sell
-5,020
Closed -$242K 483
2021
Q3
$242K Sell
5,020
-790
-14% -$38.1K 0.01% 365
2021
Q2
$306K Sell
5,810
-717
-11% -$37.8K 0.01% 315
2021
Q1
$323K Buy
6,527
+430
+7% +$21.3K 0.01% 289
2020
Q4
$296K Sell
6,097
-84
-1% -$4.08K 0.01% 287
2020
Q3
$310K Buy
6,181
+208
+3% +$10.4K 0.01% 288
2020
Q2
$305K Sell
5,973
-501
-8% -$25.6K 0.01% 270
2020
Q1
$283K Buy
6,474
+389
+6% +$17K 0.02% 255
2019
Q4
$305K Buy
6,085
+744
+14% +$37.3K 0.01% 299
2019
Q3
$247K Buy
5,341
+476
+10% +$22K 0.01% 327
2019
Q2
$210K Buy
4,865
+13
+0.3% +$561 0.01% 359
2019
Q1
$214K Buy
+4,852
New +$214K 0.01% 302